August J. Troendle - Jul 18, 2022 Form 4 Insider Report for Medpace Holdings, Inc. (MEDP)

Role
CEO, Director, 10%+ Owner
Signature
/s/ Stephen P. Ewald, Attorney-in-Fact for August J. Troendle
Stock symbol
MEDP
Transactions as of
Jul 18, 2022
Transactions value $
$1,207,850
Form type
4
Date filed
7/20/2022, 04:02 PM
Previous filing
Jul 18, 2022
Next filing
Sep 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MEDP Common Stock Purchase $1.21M +8.33K +0.15% $145.00 5.51M Jul 18, 2022 By Medpace Investors, LLC F1, F2, F3
holding MEDP Common Stock 807K Jul 18, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Medpace Investors, LLC ("MPI") on March 17, 2022, and amended on May 3, 2022.
F2 The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.885 to $145.00. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
F3 The Reporting Person is the sole manager and controlling unit holder of MPI and has sole voting and investment control with respect to the securities held by MPI. The Reporting Person may be deemed to indirectly beneficially own the securities of the Issuer held by MPI but disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.